| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070631 | European Journal of Surgical Oncology (EJSO) | 2005 | 6 Pages |
Abstract
Low-dose 99mTc-Sestamibi administered few minutes before surgery is sufficient for MIRP in patients with high likelihood of a solitary PA and without concomitant 99mTc-Sestamibi-avid thyroid nodules. The combination of radioguided surgery and QPTH measurements is very useful in the early identification of unanticipated multigland disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
D. Rubello, A. Piotto, F. Medi, M.D. Gross, B. Shapiro, P. Erba, G. Mariani, M.R. Pelizzo,